Obinutuzumab vs. rituximab with chemotherapy in follicular lymphoma

admin

7 years ago

Lauren C. Pinter-Brown MD, FACP, Health Sciences Professor of Medicine and Dermatology, Chao Family Comprehensive Cancer Center, UC-Irvine compares Obinutuzumab vs. rituximab with chemotherapy in follicular lymphoma at the MOASC Spotlight on ASH meeting 2017